Suresh B. Singh

3.7k total citations · 1 hit paper
47 papers, 2.8k citations indexed

About

Suresh B. Singh is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Suresh B. Singh has authored 47 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Computational Theory and Mathematics and 14 papers in Organic Chemistry. Recurrent topics in Suresh B. Singh's work include Computational Drug Discovery Methods (15 papers), DNA and Nucleic Acid Chemistry (8 papers) and Synthesis and biological activity (7 papers). Suresh B. Singh is often cited by papers focused on Computational Drug Discovery Methods (15 papers), DNA and Nucleic Acid Chemistry (8 papers) and Synthesis and biological activity (7 papers). Suresh B. Singh collaborates with scholars based in United States, Brazil and Israel. Suresh B. Singh's co-authors include Ya‐Jun Zheng, Colin M. Tice, Robert P. Sheridan, Mu Gao, Jeffrey Skolnick, Eugene M. Fluder, Hongyi Zhou, Peter A. Kollman, Simon K. Kearsley and Suse Broyde and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Suresh B. Singh

47 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The use of spirocyclic scaffolds in drug discovery

2014 857 citations Ya‐Jun Zheng, Colin M. Tice et al. Bioorganic & Medicinal Chemistry Letters profile →

Peers

Suresh B. Singh

CTM

ONCOL

PHARM

Joseph P. Vacca United States

Donna M. Huryn United States

Renée L. DesJarlais United States

Sandro Cosconati Italy

S. Barret Kalindjian United Kingdom

John W. Clader United States

Georgina A. Holloway Australia

John P. Mallamo United States

Fabrizio Giordanetto Sweden

Hwangseo Park South Korea

Joseph P. Vacca United States

Suresh B. Singh

2.0k ×1.5

1.8k ×1.4

639 ×1.5

CTM

317 ×1.2

ONCOL

342 ×1.6

PHARM

Citations per year, relative to Suresh B. Singh Suresh B. Singh (= 1×) peers Joseph P. Vacca

Countries citing papers authored by Suresh B. Singh

Since Specialization

Citations

This map shows the geographic impact of Suresh B. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh B. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh B. Singh more than expected).

Fields of papers citing papers by Suresh B. Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh B. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh B. Singh. The network helps show where Suresh B. Singh may publish in the future.

Co-authorship network of co-authors of Suresh B. Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh B. Singh. A scholar is included among the top collaborators of Suresh B. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh B. Singh. Suresh B. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Ya‐Jun, Colin M. Tice, & Suresh B. Singh. (2017). Conformational control in structure-based drug design. Bioorganic & Medicinal Chemistry Letters. 27(13). 2825–2837. 40 indexed citations

Lindblom, Peter, Guosheng Wu, John J. Baldwin, et al.. (2014). An electronic environment and contact direction sensitive scoring function for predicting affinities of protein–ligand complexes in Contour®. Journal of Molecular Graphics and Modelling. 53. 118–127. 4 indexed citations

Zheng, Ya‐Jun, Colin M. Tice, & Suresh B. Singh. (2014). The use of spirocyclic scaffolds in drug discovery. Bioorganic & Medicinal Chemistry Letters. 24(16). 3673–3682. 857 indexed citations breakdown →

Singh, Suresh B. & Colin M. Tice. (2010). Structure Based Design of 11β-HSD1 Inhibitors. Current Pharmaceutical Biotechnology. 11(7). 779–791. 9 indexed citations

Liang, Gui‐Bai, Xiaoxia Qian, Tesfaye Biftu, et al.. (2008). Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design. Bioorganic & Medicinal Chemistry Letters. 18(13). 3706–3710. 20 indexed citations

Biftu, Tesfaye, Giovanna Scapin, Suresh B. Singh, et al.. (2007). Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin. Bioorganic & Medicinal Chemistry Letters. 17(12). 3384–3387. 51 indexed citations

Chen, Meng‐Hsin, Suresh B. Singh, Edward A. O’Neill, et al.. (2006). Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(6). 2222–2226. 38 indexed citations

Biftu, Tesfaye, Dennis Feng, Xiaoxia Qian, et al.. (2006). (3R)-4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 17(1). 49–52. 34 indexed citations

Natarajan, S., Stephen T. Heller, Kiyean Nam, et al.. (2006). p38 MAP kinase inhibitors. Part 6: 2-Arylpyridazin-3-ones as templates for inhibitor design. Bioorganic & Medicinal Chemistry Letters. 16(22). 5809–5813. 19 indexed citations

10.

Lü, Ping, Suresh B. Singh, Brian Carr, et al.. (2005). Selective Inhibition of Dog Hepatic CYP2B11 and CYP3A12. Journal of Pharmacology and Experimental Therapeutics. 313(2). 518–528. 29 indexed citations

11.

Liu, Luping, Sangita B. Patel, James V. Pivnichny, et al.. (2003). Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 13(2). 277–280. 66 indexed citations

12.

Liu, Luping, S. Natarajan, Meng‐Hsin Chen, et al.. (2003). SAR of 3,4-Dihydropyrido[3,2-d]pyrimidone p38 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 3979–3982. 102 indexed citations

13.

Chung, Caroline, Jeffrey P. Varnerin, Nancy R. Morin, et al.. (2003). The role of tryptophan 1072 in human PDE3B inhibitor binding. Biochemical and Biophysical Research Communications. 307(4). 1045–1050. 7 indexed citations

14.

Natarajan, S., David D. Wisnoski, Suresh B. Singh, et al.. (2003). p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold. Bioorganic & Medicinal Chemistry Letters. 13(2). 273–276. 32 indexed citations

15.

Sheridan, Robert P., M. Katharine Holloway, Georgia B. McGaughey, Ralph T. Mosley, & Suresh B. Singh. (2002). A simple method for visualizing the differences between related receptor sites. Journal of Molecular Graphics and Modelling. 21(1). 71–79. 14 indexed citations

16.

Sauer, Karsten, Jen Liou, Suresh B. Singh, et al.. (2001). Hematopoietic Progenitor Kinase 1 Associates Physically and Functionally with the Adaptor Proteins B Cell Linker Protein and SLP-76 in Lymphocytes. Journal of Biological Chemistry. 276(48). 45207–45216. 98 indexed citations

17.

Parmee, Emma R., Linda Brockunier, Jiafang He, et al.. (2000). Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2283–2286. 12 indexed citations

18.

Singh, Suresh B. & Peter A. Kollman. (1996). Understanding the thermodynamic stability of an RNA hairpin and its mutant. Biophysical Journal. 70(4). 1940–1948. 14 indexed citations

19.

Singh, Suresh B., Bin Li, Brian E. Hingerty, Robert Shapiro, & Suse Broyde. (1994). Molecular Dynamics Simulation of a Tumorigenic Benzo[a]pyrene Metabolite Bound to DNA at a Single Strand‐Double Strand Junction^a. Annals of the New York Academy of Sciences. 726(1). 57–70. 4 indexed citations

20.

Singh, Suresh B., David A. Pearlman, & Peter A. Kollman. (1993). Free energy component analysis: application to the “Z-Phobicity” of A · T base pairs. Journal of Biomolecular Structure and Dynamics. 11(2). 303–311. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact